Targeted Acid-Sensing Ion Channel Therapies for Migraine
- PMID: 29549622
- PMCID: PMC5935648
- DOI: 10.1007/s13311-018-0619-2
Targeted Acid-Sensing Ion Channel Therapies for Migraine
Abstract
Acid-sensing ion channels (ASICs) are a family of ion channels, consisting of four members; ASIC1 to 4. These channels are sensitive to changes in pH and are expressed throughout the central and peripheral nervous systems-including brain, spinal cord, and sensory ganglia. They have been implicated in a number of neurological conditions such as stroke and cerebral ischemia, traumatic brain injury, and epilepsy, and more recently in migraine. Their expression within areas of interest in the brain in migraine, such as the hypothalamus and PAG, their demonstrated involvement in preclinical models of meningeal afferent signaling, and their role in cortical spreading depression (the electrophysiological correlate of migraine aura), has enhanced research interest into these channels as potential therapeutic targets in migraine. Migraine is a disorder with a paucity of both acute and preventive therapies available, in which at best 50% of patients respond to available medications, and these medications often have intolerable side effects. There is therefore a great need for therapeutic development for this disabling condition. This review will summarize the understanding of the structure and CNS expression of ASICs, the mechanisms for their potential role in nociception, recent work in migraine, and areas for future research and drug development.
Keywords: ASICs; Cortical spreading depression; Headache; Ion channels; Migraine; Therapeutics.
Figures
Similar articles
-
ASICs as therapeutic targets for migraine.Neuropharmacology. 2015 Jul;94:64-71. doi: 10.1016/j.neuropharm.2014.12.015. Epub 2015 Jan 9. Neuropharmacology. 2015. PMID: 25582295 Free PMC article. Review.
-
Acid-Sensing Ion Channels and nociception in the peripheral and central nervous systems.Neuropharmacology. 2015 Jul;94:49-57. doi: 10.1016/j.neuropharm.2015.02.009. Epub 2015 Feb 24. Neuropharmacology. 2015. PMID: 25724084 Review.
-
Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.Br J Pharmacol. 2018 Nov;175(21):4154-4166. doi: 10.1111/bph.14462. Epub 2018 Sep 22. Br J Pharmacol. 2018. PMID: 30079481 Free PMC article.
-
The pharmacology and therapeutic potential of small molecule inhibitors of acid-sensing ion channels in stroke intervention.Acta Pharmacol Sin. 2013 Jan;34(1):33-8. doi: 10.1038/aps.2012.81. Epub 2012 Jul 23. Acta Pharmacol Sin. 2013. PMID: 22820909 Free PMC article. Review.
-
Acid-Sensing Ion Channels as Potential Pharmacological Targets in Peripheral and Central Nervous System Diseases.Adv Protein Chem Struct Biol. 2016;103:137-67. doi: 10.1016/bs.apcsb.2015.10.002. Epub 2015 Nov 21. Adv Protein Chem Struct Biol. 2016. PMID: 26920689 Review.
Cited by
-
The Role of ASIC1a in Epilepsy: A Potential Therapeutic Target.Curr Neuropharmacol. 2021;19(11):1855-1864. doi: 10.2174/1570159X19666210402102232. Curr Neuropharmacol. 2021. PMID: 33797385 Free PMC article. Review.
-
Involvement of Potassium Channel Signalling in Migraine Pathophysiology.Pharmaceuticals (Basel). 2023 Mar 14;16(3):438. doi: 10.3390/ph16030438. Pharmaceuticals (Basel). 2023. PMID: 36986537 Free PMC article. Review.
-
New Oral Drugs for Migraine.CNS Drugs. 2022 Sep;36(9):933-949. doi: 10.1007/s40263-022-00948-8. Epub 2022 Aug 29. CNS Drugs. 2022. PMID: 36031682 Free PMC article. Review.
-
Mechanisms of Action of the Peptide Toxins Targeting Human and Rodent Acid-Sensing Ion Channels and Relevance to Their In Vivo Analgesic Effects.Toxins (Basel). 2022 Oct 17;14(10):709. doi: 10.3390/toxins14100709. Toxins (Basel). 2022. PMID: 36287977 Free PMC article. Review.
-
Relevance of lactate level detection in migrane and fibromyalgia.Eur J Transl Myol. 2019 May 9;29(2):8202. doi: 10.4081/ejtm.2019.8202. eCollection 2019 May 7. Eur J Transl Myol. 2019. PMID: 31354925 Free PMC article.
References
-
- Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9. - PubMed
-
- Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–32. - PubMed
-
- The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629–808. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous